Search for: "Doe v. Cephalon, Inc. et al"
Results 1 - 11
of 11
Sorted by Relevance
|
Sort by Date
19 Oct 2009, 4:30 am
Central Regional Employees Benefit Fund, et al. v. [read post]
17 Mar 2011, 7:47 am
" Cephalon Inc., et. al. v. [read post]
24 Mar 2010, 4:45 am
(Patent Docs) (Patent Quality Review Blog) Nuvigil (Armodafinil) – US: Patent infringement complaint filed following a Para IV certification: Cephalon, Inc. et al. v. [read post]
16 Dec 2009, 3:39 am
Perrigo Co. et al. [read post]
29 Jul 2013, 12:16 pm
Cephalon Inc. et al. v. [read post]
8 Oct 2009, 6:05 am
Teva Pharmaceuticals USA, Inc (Patent Docs) (Patent Baristas) (GenericsWeb) General Biotech legislative agenda: healthcare, energy, patents and capital (IP Watch) India: Applying for patents does pay: Wockhardt wins kudos from the Indian government (SPICY IP) US: CAFC ruling in Board of Trustees of the Leland Stanford Junior University et al v Roche Molecular Systems et al - How to lose a patent? [read post]
24 Nov 2010, 12:37 am
Use of pipeline system (IP tango) EU: Notes from EU Parliament meeting on innovation+access for medical technologies (KEI) Netherlands: District Court of The Hague declares Dutch part of Bayer’s European patent covering anti-TNF alpha human monoclonal antibodies invalid (Kluwer Patent Blog) Southeast Asia: Generic drug market picks up steam in Southeast Asia, finds Front & Sullivan (GenericsWeb) Spain: Commercial Court No 5 of Barcelona: obtaining price for generic medicament an act of… [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
18 Jun 2019, 6:42 am
Pileggi, et al., Inspecting Corporate “Books and Records” in a Digital World: The Role of Electronically Stored Information, 37 Del. [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners:… [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous system stem cell and… [read post]
